| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.39 | 0.002 |